Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis
出版年份 2020 全文链接
标题
Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis
作者
关键词
-
出版物
JOURNAL OF DERMATOLOGICAL TREATMENT
Volume -, Issue -, Pages 1-11
出版商
Informa UK Limited
发表日期
2020-06-08
DOI
10.1080/09546634.2020.1775775
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statement
- (2019) Y.A. Leshem et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The use of biologics for immune modulation in allergic disease
- (2019) Willem van de Veen et al. JOURNAL OF CLINICAL INVESTIGATION
- GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis
- (2019) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis
- (2019) Thomas Bieber ALLERGY
- Nemolizumab in moderate to severe atopic dermatitis: An exploratory analysis of work productivity and activity impairment in a randomized phase II study
- (2019) Ryosuke Mihara et al. JOURNAL OF DERMATOLOGY
- Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
- (2019) Jonathan I. Silverberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis
- (2019) Yi-Ling Chen et al. Science Translational Medicine
- New and developing therapies for atopic dermatitis
- (2018) Tamar Hajar et al. ANAIS BRASILEIROS DE DERMATOLOGIA
- Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study
- (2018) Kenji Kabashima et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb
- (2018) Andreas Wollenberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Emerging therapies for atopic dermatitis: TRPV1 antagonists
- (2018) Jonathan G. Bonchak et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
- (2018) Emma Guttman-Yassky et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II
- (2018) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Developing drugs for treatment of atopic dermatitis in children (≥3 months to
- (2018) Elaine C. Siegfried et al. PEDIATRIC DERMATOLOGY
- Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab
- (2018) Patrick M. Brunner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tezepelumab, an anti-TSLP monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Therapeutic pipeline for atopic dermatitis: End of the drought?
- (2017) Amy S. Paller et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Expression of IL-22 in the Skin Causes Th2-Biased Immunity, Epidermal Barrier Dysfunction, and Pruritus via Stimulating Epithelial Th2 Cytokines and the GRP Pathway
- (2017) Hongfei Lou et al. JOURNAL OF IMMUNOLOGY
- Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
- (2017) B. Popovic et al. JOURNAL OF MOLECULAR BIOLOGY
- Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
- (2017) Thomas Ruzicka et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march
- (2016) Gyohei Egawa et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The pruritus- and T H 2-associated cytokine IL-31 promotes growth of sensory nerves
- (2016) Micha Feld et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Control of the Physical and Antimicrobial Skin Barrier by an IL-31–IL-1 Signaling Network
- (2016) Kai H. Hänel et al. JOURNAL OF IMMUNOLOGY
- Influence of Th2 Cytokines on the Cornified Envelope, Tight Junction Proteins, and β-Defensins in Filaggrin-Deficient Skin Equivalents
- (2016) Stefan Hönzke et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities
- (2015) C. G. Mortz et al. ALLERGY
- OX40, OX40L and Autoimmunity: a Comprehensive Review
- (2015) Gwilym J. Webb et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Efficacy and safety of tralokinumab in patients with severe uncontrolled asthma: a randomised, double-blind, placebo-controlled, phase 2b trial
- (2015) Christopher E Brightling et al. Lancet Respiratory Medicine
- Biological Treatments in Atopic Dermatitis
- (2015) Andrea Montes-Torres et al. Journal of Clinical Medicine
- Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis
- (2014) Atsuhiko Kato et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Basophils Promote Innate Lymphoid Cell Responses in Inflamed Skin
- (2014) Brian S. Kim et al. JOURNAL OF IMMUNOLOGY
- A new itch to scratch for TSLP
- (2014) Matthew J. Turner et al. TRENDS IN IMMUNOLOGY
- Atopic dermatitis and the atopic march revisited
- (2013) S. C. Dharmage et al. ALLERGY
- The Epithelial Cell-Derived Atopic Dermatitis Cytokine TSLP Activates Neurons to Induce Itch
- (2013) Sarah R. Wilson et al. CELL
- Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma
- (2013) Swati Agrawal et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- A sensory neuron–expressed IL-31 receptor mediates T helper cell–dependent itch: Involvement of TRPV1 and TRPA1
- (2013) Ferda Cevikbas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- TRPA1-Dependent Pruritus in IL-13-Induced Chronic Atopic Dermatitis
- (2013) M.-H. Oh et al. JOURNAL OF IMMUNOLOGY
- Structural Basis of Signaling Blockade by Anti-IL-13 Antibody Lebrikizumab
- (2013) Mark Ultsch et al. JOURNAL OF MOLECULAR BIOLOGY
- Chronic Pruritus
- (2013) Gil Yosipovitch et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-31 Expression by Inflammatory Cells is Preferentially Elevated in Atopic Dermatitis
- (2012) GFL Hofbauer et al. ACTA DERMATO-VENEREOLOGICA
- Signaling by IL-31 and functional consequences
- (2011) Christian Cornelissen et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
- (2011) Mark Boguniewicz et al. IMMUNOLOGICAL REVIEWS
- IL-13 Induces Skin Fibrosis in Atopic Dermatitis by Thymic Stromal Lymphopoietin
- (2011) M.-H. Oh et al. JOURNAL OF IMMUNOLOGY
- IL-13 Antibodies Influence IL-13 Clearance in Humans by Modulating Scavenger Activity of IL-13R 2
- (2011) M. T. Kasaian et al. JOURNAL OF IMMUNOLOGY
- Cytokine modulation of atopic dermatitis filaggrin skin expression
- (2009) Michael D. Howell et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- IL-22–producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17–producing TH17 T cells
- (2009) Kristine E. Nograles et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Structures and biological functions of IL-31 and IL-31 receptors
- (2008) Qing Zhang et al. CYTOKINE & GROWTH FACTOR REVIEWS
- “Outside-to-Inside” (and Now Back to “Outside”) Pathogenic Mechanisms in Atopic Dermatitis
- (2008) Peter M. Elias et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Atopic Dermatitis
- (2008) Thomas Bieber NEW ENGLAND JOURNAL OF MEDICINE
- TSLP acts on infiltrating effector T cells to drive allergic skin inflammation
- (2008) R. He et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structure of IL-22 Bound to Its High-Affinity IL-22R1 Chain
- (2008) Brandi C. Jones et al. STRUCTURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now